These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9017147)

  • 1. Acquisition of susceptibility to vesicular stomatitis virus infection by murine resident peritoneal cells during culturing in vitro.
    Orzechowska B; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 1996; 44(5-6):325-8. PubMed ID: 9017147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral effect of proline-rich polypeptide in murine resident peritoneal cells.
    Orzechowska B; Janusz M; Domaraczenko B; Błach-Olszewska Z
    Acta Virol; 1998 Apr; 42(2):75-8. PubMed ID: 9770073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of cyclosporine A on the non-specific, innate antiviral immunity of mice.
    Zaczyńska E; Olszewska ZB
    Arch Immunol Ther Exp (Warsz); 2001; 49 Suppl 1():S53-7. PubMed ID: 11603870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
    Orzechowska B; Antoszków Z; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activity of Bordetella pertussis vaccine-elicited peritoneal exudate cells.
    Baggett DW; LeBlanc PA; Allison FS; Thomley MJ; Winters AL
    J Immunopharmacol; 1986; 8(4):589-609. PubMed ID: 3027186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between the lipopolysaccharide response of mice and the capacity of mouse peritoneal cells to transfer an antiviral state. Role of endogenous interferon.
    Gessani S; Belardelli F; Borghi P; Boraschi D; Gresser I
    J Immunol; 1987 Sep; 139(6):1991-8. PubMed ID: 3040861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
    Ahmed M; Cramer SD; Lyles DS
    Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection.
    Trottier MD; Palian BM; Reiss CS
    Virology; 2005 Mar; 333(2):215-25. PubMed ID: 15721356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigen-activated T cells redirected by a bispecific antibody inhibit vesicular stomatitis virus replication in vitro and in vivo.
    Fernandez-Sesma A; Peluso RW; Bai X; Schulman JL; Levy DE; Moran TM
    J Immunol; 1998 Feb; 160(4):1841-9. PubMed ID: 9469445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell regulation of pokeweed-mitogen-induced polyclonal immunoglobulin production in mice. III. Role of Lyt 1+2- non-helper T cells in the suppression.
    Kina T; Nishikawa S; Katsura Y
    Immunology; 1982 Nov; 47(3):525-30. PubMed ID: 6290381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-induced guanylate binding protein-1 (GBP-1) mediates an antiviral effect against vesicular stomatitis virus and encephalomyocarditis virus.
    Anderson SL; Carton JM; Lou J; Xing L; Rubin BY
    Virology; 1999 Mar; 256(1):8-14. PubMed ID: 10087221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle requisite for vesicular stomatitis virus replication in T lymphocytes activated with concanavalin A.
    Fujisawa H; Kumazawa Y; Ohtani A; Nishimura C
    J Clin Lab Immunol; 1984 Jan; 13(1):41-6. PubMed ID: 6325697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell priming against vesicular stomatitis virus analyzed in situ: red pulp macrophages, but neither marginal metallophilic nor marginal zone macrophages, are required for priming CD4+ and CD8+ T cells.
    Ciavarra RP; Buhrer K; Van Rooijen N; Tedeschi B
    J Immunol; 1997 Feb; 158(4):1749-55. PubMed ID: 9029112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
    Porosnicu M; Mian A; Barber GN
    Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis as pathogenic mechanism of infection with vesicular stomatitis virus. Evidence in primary bovine fibroblast cultures.
    López-Herrera A; Ruiz-Sáenz J; Góez YP; Zapata W; Velilla PA; Arango AE; Urcuqui-Inchima S
    Biocell; 2009 Aug; 33(2):121-32. PubMed ID: 19886040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of the interferon-mediated antiviral state to vesicular stomatitis virus in resting mouse peritoneal macrophages.
    Di Francesco P; Coccia EM; Gessani S; Romeo G; Borghi P; Locardi C; Belardelli F
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1899-905. PubMed ID: 2544669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age related natural antiviral non-specific immunity of human leukocytes.
    Rybka K; Orzechowska B; Siemieniec I; Leszek J; Zaczynska E; Pajak J; Błach-Olszewska Z
    Med Sci Monit; 2003 Dec; 9(12):BR413-7. PubMed ID: 14646969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of endogenous interferon and LPS in the immunomodulatory effects of bovine lactoferrin in murine peritoneal macrophages.
    Puddu P; Carollo MG; Belardelli F; Valenti P; Gessani S
    J Leukoc Biol; 2007 Aug; 82(2):347-53. PubMed ID: 17475783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncolytic vesicular stomatitis viruses are potent agents for intravesical treatment of high-risk bladder cancer.
    Hadaschik BA; Zhang K; So AI; Fazli L; Jia W; Bell JC; Gleave ME; Rennie PS
    Cancer Res; 2008 Jun; 68(12):4506-10. PubMed ID: 18559493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donepezil on innate antiviral immunity of human leukocytes.
    Sochocka M; Zaczyńska E; Leszek J; Siemieniec I; Błach-Olszewska Z
    J Neurol Sci; 2008 Oct; 273(1-2):75-80. PubMed ID: 18662817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.